Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05455281 · ClinicalTrials.gov registry record
Performance of CHLOE Algorithm on the Prediction of Blastocyst Formation
A clinical trial, sponsored by Fairtility.
- Completed
- Registry status
- 55
- Enrollment target
NCT05455281 is a clinical trial that has completed, run by Fairtility. The registered enrollment target is 55 participants.
The verdict
NCT05455281 has completed, sponsored by Fairtility.
- COMPLETED
- Registry status
- 55 participants
- Enrollment target
Study Summary
This is an observational, prospective, single-arm, multi-center, clinical study to evaluate the performance of CHLOE, an Artificial Intelligence (AI)-based software application, as adjunct information to support identifying embryos on Day 3 that are most likely to form blastocysts.
Interventions
- DEVICE CHLOE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2022-07-27 |
| Est. Completion | 2023-07-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05455281
The ClinicalTrials.gov registry entry for NCT05455281 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fairtility, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CHLOE is the first listed.
NCT05455281 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05455281 about?
NCT05455281 is a clinical study titled "Performance of CHLOE Algorithm on the Prediction of Blastocyst Formation". This is an observational, prospective, single-arm, multi-center, clinical study to evaluate the performance of CHLOE, an Artificial Intelligence (AI)-based software application, as adjunct information to support identifying embryos on Day 3 that are most likely to form blastocysts.
What is the current status of trial NCT05455281?
This trial is currently completed. The enrollment target is 55 participants. The study started on 2022-07-27. Estimated completion is 2023-07-27.
What interventions are being tested in trial NCT05455281?
The interventions under investigation include: CHLOE (DEVICE).
Who is sponsoring clinical trial NCT05455281?
This trial is sponsored by Fairtility, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.